We can’t show the full text here under this license.
Abstract
An mRNA vaccine encoding hemagglutinin from A/Texas/37/2024 may confer complete protection against lethal H5N1 influenza in murine models.
- Both wild-type and modified hemagglutinin vaccines elicit robust and durable immune responses.
- The vaccine stimulates a balanced Th1/Th2 immune response.
- Cross-clade binding antibody responses are observed, with improved effectiveness against specific clades at a 1 μg dose.
- Pre-existing immunity to H1 does not reduce the immunogenicity of the H5 vaccine.
- In avian species, the vaccine provides full protection against lethal strains of H5N1.
- The vaccine shows a favorable safety profile in rat models.
Simplified